Heterogeneity of nemaline myopathy cases with skeletal muscle alpha-actin gene mutations

Annals of Neurology
Pankaj B AgrawalA H Beggs

Abstract

Nemaline myopathy (NM) is the most common of several congenital myopathies that present with skeletal muscle weakness and hypotonia. It is clinically heterogeneous and the diagnosis is confirmed by identification of nemaline bodies in affected muscles. The skeletal muscle alpha-actin gene (ACTA1) is one of five genes for thin filament proteins identified so far as responsible for different forms of NM. We have screened the ACTA1 gene in a cohort of 109 unrelated patients with NM. Here, we describe clinical and pathological features associated with 29 ACTA1 mutations found in 38 individuals from 28 families. Although ACTA1 mutations cause a remarkably heterogeneous range of phenotypes, they were preferentially associated with severe clinical presentations (p < 0.0001). Most pathogenic ACTA1 mutations were missense changes with two instances of single base pair deletions. Most patients with ACTA1 mutations had no prior family history of neuromuscular disease (24/28). One severe case, caused by compound heterozygous recessive ACTA1 mutations, demonstrated increased alpha-cardiac actin expression, suggesting that cardiac actin might partially compensate for ACTA1 abnormalities in the fetal/neonatal period. This cohort also includes...Continue Reading

Associated Clinical Trials

References

Oct 1, 1992·Genetics·K F WertmanD Botstein
May 1, 1997·Neuromuscular Disorders : NMD·H H GoebelI Warlo
Apr 1, 1997·Neuropediatrics·M LammensR Dom
Oct 10, 1997·Journal of Medical Genetics·K N NorthC Wallgren-Pettersson
Jan 22, 1998·The American Journal of Physiology·T CollinsE C Hardeman
Jul 24, 1998·Biochemical and Biophysical Research Communications·Y ChanL M Kunkel
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·K PelinC Wallgren-Pettersson
Jan 5, 2000·Neuromuscular Disorders : NMD·C Wallgren-PetterssonA de la Chapelle
Jun 6, 2000·Neuromuscular Disorders : NMD·C Wallgren-Pettersson, N G Laing
Aug 23, 2000·American Journal of Human Genetics·J J JohnstonL G Biesecker
May 3, 2001·American Journal of Human Genetics·B IlkovskiK N North
Sep 18, 2001·Annals of Neurology·M M RyanK N North
Dec 12, 2001·Neuromuscular Disorders : NMD·Kati DonnerCarina Wallgren-Pettersson
Sep 5, 2002·Neuromuscular Disorders : NMD·Carina Wallgren-PetterssonKatarina Pelin
Sep 5, 2002·Neuromuscular Disorders : NMD·Katarina PelinCarina Wallgren-Pettersson
Aug 19, 2003·Neuromuscular Disorders : NMD·John C SparrowNigel G Laing
Dec 23, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Kinga K TomczakAlan H Beggs
Jan 22, 2004·Neuromuscular Disorders : NMD·Steven MarstonCaroline Sewry

❮ Previous
Next ❯

Citations

Jun 25, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Julien Ochala
Jul 10, 2013·Der Nervenarzt·F HanischS Zierz
Jul 25, 2012·Acta Neuropathologica·Kristen J NowakNigel G Laing
Apr 19, 2012·European Journal of Human Genetics : EJHG·Kristen J NowakNigel G Laing
May 15, 2008·The Journal of Biological Chemistry·Becky M Miller, Kathleen M Trybus
Feb 10, 2011·Brain : a Journal of Neurology·Gianina RavenscroftKristen J Nowak
Jun 6, 2013·Human Molecular Genetics·Gianina RavenscroftKristen J Nowak
Jan 18, 2007·BMC Cell Biology·Friederike S BatheLaura M Machesky
Jun 25, 2014·The Journal of Clinical Investigation·Ankit GargEric N Olson
Jun 13, 2006·Journal of Cardiovascular Electrophysiology·Jeffrey A Towbin, Neil E Bowles
Sep 9, 2015·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Jonathan EnnisHugh J McMillan
Feb 26, 2015·European Journal of Human Genetics : EJHG·Kristen J NowakNigel G Laing
Dec 4, 2014·Nature·Julian von der EckenStefan Raunser
Jan 25, 2014·Neuromuscular Disorders : NMD·Kathryn N NorthUNKNOWN International Standard of Care Committee for Congenital Myopathies
Oct 10, 2006·Seminars in Pediatric Neurology·Hans H Goebel, Harald D Müller
Mar 30, 2005·Journal of Child Neurology·Hans H Goebel
Oct 21, 2004·The Journal of Pathology·Emilie ClarksonLaura M Machesky
Aug 5, 2014·Muscle & Nerve·Claudia CastiglioniJorge A Bevilacqua
Jul 15, 2015·Muscle & Nerve·Nanna WittingJohn Vissing
Aug 23, 2017·ELife·Andres Ramirez-MartinezEric N Olson
Feb 17, 2007·American Journal of Physical Medicine & Rehabilitation·Feriha OzerVildan Yayla
Dec 26, 2006·Annals of Neurology·Kristen J NowakNigel G Laing
Feb 12, 2009·Muscle & Nerve·John WhitakerMartin Plummeridge
Mar 20, 2009·Cell Motility and the Cytoskeleton·Davina TondeleirAnja Lambrechts
Jul 1, 2009·Brain Pathology·Hans H Goebel, Nigel G Laing
Jun 30, 2009·Human Mutation·Nigel G LaingKristen J Nowak
Mar 2, 2010·Yonsei Medical Journal·Ji-Man HongYoung-Chul Choi
Mar 17, 2010·Muscle & Nerve·Roy H Rhodes, Leroy R Sharer
Jul 15, 2005·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Nigel G Laing, Kristen J Nowak
Feb 16, 2006·Muscle & Nerve·Vassil KaimaktchievRandal Nixon
Feb 17, 2019·The Journal of Physiology·William Schmidt, Anthony Cammarato
Mar 28, 2007·Annals of Neurology·Nigel F ClarkeKathryn North
Jun 1, 2018·Acta Neuropathologica Communications·Tamar E SztalRobert J Bryson-Richardson
Jul 31, 2019·Journal of Neuropathology and Experimental Neurology·Han-Chih Hencher LeeChloe Miu Mak
Sep 25, 2014·The Journal of Clinical Investigation·Michaela YuenNigel F Clarke
Sep 3, 2013·Current Opinion in Neurology·Norma B RomeroNigel F Clarke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.